Tick 39 — 2026-05-22 11:30 UTC

Thread: ADR-114 (cog-quantum-vitals) — first concrete quantum-augmented cog spec Verdict: Recovers R13 NEGATIVE with a buildable spec. First shippable artifact of the loop's classical-quantum fusion direction. 5y deployable.

What shipped

• docs/adr/ADR-114-cog-quantum-vitals.md — full ADR for first quantum-augmented cog.

Why this tick (user signal x3)

User opened docs/research/quantum-sensing/11-quantum-level-sensors.md THREE times across consecutive ticks (tick 37, 38, 39). Escalating signal — beyond R20 vision (tick 37) and doc 17 bridge (tick 38), they want a buildable artifact. ADR-114 is that.

Headline architecture

ESP32 CSI ──▶ R14 V1 breathing rate ──┐
              R12.1 pose-PABS ────────┤
nvsim NV ──▶ R6.1 multi-source forward├──▶ Bayesian fusion ──▶ vitals
              R3+AETHER patient ID ────┘

• Breathing rate: ±0.1 BPM (classical primary, NV cross-check)
• Heart rate: ±0.5 BPM (NV primary, classical cross-check)
• HRV contour: NV only (R13 NEGATIVE rules out classical)
• Per-patient identity: R3 + AETHER
• Confidence score per output

Honest range: 1-2 m bedside

Inherits doc 16's posture. Cube-of-distance falloff bounds extension. Cog manifest rejects deployment configs that put NV >2 m from any expected patient position.

Cost analysis

Implementation: ~200 LOC, ~3 weeks

Privacy chain stays intact

Inherits ADR-105 / ADR-106 / ADR-107 / ADR-108 / ADR-109:

• ✅ Raw NV B(t) on-device only (ADR-106 Layer 1)
• ✅ Per-patient HRV contour on-device only
• ⚠️ Aggregated rates emittable with consent
• ⚠️ Model updates federated w/ DP-SGD

ADR-100 + ADR-109 dual-signing for manifest. No regulatory delta from existing privacy framework.

R14 V3 becomes shippable

R14 V3 (attention-respecting conversational appliance) was previously bound by R13's contour requirement. ADR-114 provides the contour → V3 ships.

What R20 + doc 17 + ADR-114 progression accomplished

• R20 (tick 37): vision — quantum sensors recover classical limits
• Doc 17 (tick 38): integration — bridges loop with quantum-sensing series
• ADR-114 (this tick): shippable — concrete cog spec, $310-$2,110/bedside

The three-tick arc went from vision → integration → buildable artifact in 35 minutes.

ADR chain after this tick

10 ADRs in the loop's accumulated chain:

• ADR-100 cog packaging (existing)
• ADR-103 cog-person-count (existing)
• ADR-104 MCP+CLI (existing)
• ADR-105 within-install federation (loop)
• ADR-106 DP-SGD + isolation (loop)
• ADR-107 cross-install + SA (loop)
• ADR-108 PQC key exchange (loop)
• ADR-109 PQC signatures (loop)
• ADR-113 multistatic placement (loop)
• ADR-114 cog-quantum-vitals (loop, this tick)

Plus ADR-089 (nvsim) referenced as critical dependency.

Future ADRs catalogued

• ADR-115: cog-rydberg-anchor (7-10y, calibrated multistatic)
• ADR-116: real NV hardware bring-up
• ADR-117: cog-quantum-vitals FDA/CE pathway
• ADR-118: cog-mm-position (atomic-clock multistatic)

Honest scope

• nvsim is deterministic SIMULATOR; cog ships with synthetic quantum benefit until ~2028-2030 hardware
• Cube-of-distance bounds ≤2 m bedside
• Patient-side variability requires per-patient calibration
• Implementation cost conservative; Bayesian fusion may need +100 LOC if complex
• No bench validation yet on full hybrid pipeline

Composes with every loop thread

R3 / R6.1 / R12 / R12.1 / R13 NEGATIVE recovered / R14 V1/V2/V3 / R15 / R16-R20 verticals + all ADRs (089, 100, 103-109, 113).

Coordination

ticks/tick-39.md. No PROGRESS.md edit. Branch research/sota-adr114-cog-quantum-vitals.

Loop status (39 ticks, ~25 minutes to cron stop)

• 18 research threads (R1, R3, R5-R15, R16-R20)
• 8 exotic verticals + cross-series synthesis + cog spec
• 7 loop ADRs (105-109, 113, 114) + 3 existing
• Quantum-sensing series referenced (docs 11-17)
• 3 negative result categories (R13 conditionally recoverable; ADR-114 provides the recovery)
• Production roadmap + quantum-classical fusion roadmap shipped
• First buildable quantum-augmented cog spec shipped

00-summary.md to follow at 12:00 UTC stop.